Therapy of Type 1 Diabetes Mellitus
作者： Pejman Cohan , Anne L. Peters
DOI: 10.1007/978-0-387-09841-8_43
关键词:
摘要: The treatment of type 1 diabetes is simple in theory: replace the missing endogenous production insulin with exogenous a manner that mimics normal physiology. difficulties doing this are myriad, however, part stemming from fact delivered intricate pulses to portal circulation whereas provided subcutaneously through peripheral circulation. Additionally, beta cells pancreas sense minute changes blood sugar levels and secrete insulin, glucagon, amylin, incretins, other hormones balance levels. traditional monitoring four times per day two three injections does not come close even approximately what should be happening regards regulation.
springer.com
sci-hub.st 参考文章(140)
Continuous glucose monitoring in children with type 1 diabetes. The Journal of Pediatrics. ,vol. 151, pp. 388- ,(2007) , 10.1016/J.JPEDS.2007.03.047
B G Scheer, K V Sitz, Suspected insulin anaphylaxis and literature review The Journal of the Arkansas Medical Society. ,vol. 97, pp. 311- 313 ,(2001)
Kjeld Hermansen, Per Lund, Kurt Clemmensen, Leif Breum, Marianne Kleis Moller, Anne Mette Rosenfalck, Erik Christiansen, Danish PREDICTIVE study group, None, 3-Month Results from Denmark within the Globally Prospective and Observational Study to Evaluate Insulin Detemir Treatment in Type 1 and Type 2 Diabetes: The PREDICTIVE Study. The review of diabetic studies : RDS. ,vol. 4, pp. 89- 97 ,(2007) , 10.1900/RDS.2007.4.89
E. A. M. Gale, P. J. Bingley, P. J. Bingley . E. A. M. Gale . The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk ,(2006)
JS Skyler, D Brown, HP Chase, E Collier, C Cowie, GS Eisenbarth, J Fradkin, G Grave, C Greenbaum, RA Jackson, FR Kaufman, JP Krischer, JB Marks, JP Palmer, A Ricker, DA Schatz, D Wilson, WE Winter, J Wolfsdorf, A Zeidler, H Dickler, RC Eastman, NK Maclaren, JI Malone, PR Robertson, D Cuthbertson, LM Rafkin-Mervis, K Herold, L Rafkin-Mervis, B Aneju, D Conboy, R Cook, MA Dennis, L Finney, S Harris, D Matheson, M McCulloch-Olsen, T Smith, J Valenzuela, N Vega, OB Crofford, D DeMets, JM Lachin, A Rossini, A Schiffrin, M Steffes, A Tsiatis, B Zinman, Effects of insulin in relatives of patients with type 1 diabetes mellitus The New England Journal of Medicine. ,vol. 346, pp. 1685- 1691 ,(2002) , 10.1056/NEJMOA012350
, Evaluation of Factors Affecting CGMS Calibration Diabetes Technology & Therapeutics. ,vol. 8, pp. 318- 325 ,(2006) , 10.1089/DIA.2006.8.318
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, None, Continuous glucose monitoring and intensive treatment of type 1 diabetes. The New England Journal of Medicine. ,vol. 359, pp. 1464- 1476 ,(2008) , 10.1056/NEJMOA0805017
R??gis P Radermecker, G??rald E Pi??rard, Andr?? J Scheen, Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. American Journal of Clinical Dermatology. ,vol. 8, pp. 21- 28 ,(2007) , 10.2165/00128071-200708010-00003
Diabetes Control and Complications Trial, None, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine. ,vol. 353, pp. 2643- 2653 ,(2005) , 10.1056/NEJMOA052187
Jeffrey B. Matthews, Eleanor Ramos, Jeffrey A. Bluestone, Clinical Trials of Transplant Tolerance: Slow But Steady Progress American Journal of Transplantation. ,vol. 3, pp. 794- 803 ,(2003) , 10.1046/J.1600-6135.2003.0154.X